Leishmaniasis

©WHO/Patient with visceral leishmaniasis, with bleeding, from Kapoeta, South Sudan, 2013

The Leishmaniases are diseases caused by protozoan parasites from more than 20 Leishmania species that are transmitted to humans by the bites of infected female phlebotomine sandflies.

There are three main forms of the disease: cutaneous, visceral and mucocutaneous: cutaneous leishmaniasis, visceral leishmaniasis or kala-azar, and mucocutaneous leishmaniasis.

fact buffet

Visceral

300 000Estimated cases of visceral leishmaniasis (VL) and over 20, 000 deaths annually

Status of endemicity of visceral leishmaniasis, worlwide, 2012

Cutaneous

1 millionCases of cutaneous leishmaniasis (CL) reported in the last 5 years.

Status of endemicity of cutaneous leishmaniasis, worlwide, 2012

At risk

310 millionPeople at risk of infection in six countries reporting over 90% VL cases worldwide.

Second WHO report on NTDs
Chapter 3.9, page 67–71

Fact sheet

Leishmaniasis

N°375, updated January 2014

NTD Roadmap

Accelerating work to overcome the global impact of Neglected Tropical Diseases - A roadmap for implementation

Technical Report series (TRS)

The control of the leishmaniases (N°949)

Data and Maps

Leishmaniasis in the news

20 March 2013 | Geneva
Report of a WHO consultative meeting on developing a manual for case-management, prevention and control of post-kala-azardermal leishmaniasis. Kolkata, India, 2–3 July 2012.

30 May 2012 | Geneva
Leishmaniasis: epidemiology and access to medicines − an update based on the outcomes of WHO regional meetings, literature review and experts' opinion.